All companies
Visit website
NASCEND, PBC
OperatingNascend, PBC
Healthcare · Technology · Founded 2016
New paradigm of care for NAS
Valuation cap ⓘ
$6.0M
As of Jul 2024 · from NASCEND, PBC Fuure Equity SAFE 2 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$161,375
Across 2 rounds since 2023
Latest share price
$12.36
NASCEND Common Stock 1 offering price
Financials
FY2021–FY2022 · from SEC filings · hover any figure for its source$146K
−$191K
2021
$83K
−$289K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
Income statement
Revenue
$145,783
$83,183
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$191,024
-$288,758
Taxes paid
$0
$0
Balance sheet
Cash
$408,032
$125,245
Accounts receivable
$0
$0
Total assets
$424,025
$140,958
Short-term debt
$176,573
$130,566
Long-term debt
$523,543
$497,321
Total liabilities
$700,116
$627,887
Other
Headcount
—
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$5.8M
post-money
$6.0M
Valuation cap
NASCEND Common Stock 1
NASCEND, PBC Fuure Equity SAFE 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $161.4K / $1.2MInvestors 26Valuation cap $6M
Raised $0 / $1.2MInvestors 22Post-money $5.8M
Reg CF annual-report compliance
Delinquent
Filed 0 of 3 annual reports (FY2023–FY2025)
Missing: 2023, 2024, 2025
26 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001983509Share price $12.36
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.